About
Innovation,
Driven our way
Our brilliant team of scientists and engineers strives to develop transformative immunotherapeutics through innovative technologies and creative partnerships to benefit patients with unmet needs.
Amberstone’s Core Team
George Wu, Ph.D.
CEO & Cofounder
Yonglei Shang, MD, MS
Interim CTO
Lei Zheng, M.D., Ph.D.
Interim CMO &
Chief Medical Advisor
Aude Segaliny, Ph.D.
Vice President,
Research & Development
Weian Zhao, Ph.D.
Advisor & Cofounder
Scientific Advisory Board
Philip Tagari
Ming Li, Ph.D.
Robert Kiss, Ph.D., P.E.
Jane Gross, PH.D.
Lei Zheng, M.D., Ph.D.